Trial intelligence / Profile preview

Lidocaine vs Articaine for MIH in Children

NCT05200884Phase 2Completed

Sponsor
Tishreen University
Start
Jan 2022
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of articaine in Molar incisor hypomineralization (MIH), sponsored by Tishreen University. Started Jan 2022; status: completed.

02

Drugs

articaine
03

Conditions

Molar incisor hypomineralization (MIH)

Beyond the preview

Go deeper on NCT05200884.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05200884.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call